I first wrote a blog post of this story yesterday.
by David Prentice
December 14, 2009
The latest success story comes from Australia. Ben Leahy, 20, was in a wheelchair and experiencing vision problems when he was treated earlier in 2009. Ben is now walking after treatment with adult stem cells. The treatment involves isolating the patient’s bone marrow adult stem cells, giving the patient mild chemotherapy to destroy the rogue immune cells that are attacking the nervous system, then re-injecting the patient’s adult stem cells.
While the Australian group has not yet published their results, the technique mirrors the treatment results published in 2009 in Lancet Neurology by Dr. Richard Burt’s team at Northwestern, where they reported that they had reversed the neurological dysfunction of early-stage multiple sclerosis patients.
As Dr. Burt noted:
“This is the first time we have turned the tide on this disease.”
CLICK HERE to continue reading and to watch MS Patient videos of this treatment
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Keep up-to-date with MS related News (as seen above), when registered with us. Visit our website to register NOW. It will not take more than 30 seconds to register and once accomplished, you will then receive our weekly MS related e-Newsletter, which is currently being received in 58 countries by more than 6000 e-recipients. Click HERE to register. – Thank You
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- video: Optic Neuritis MRI Orbits Findings
- video: Remyelination in MS
- video: Curious about early MS symptoms doctors often miss?
- video: SMALL IMPROVEMENTS Matter
- video: Multiple Sclerosis Progression, Independent from relapse Activity
- Living with MS: Sometimes One Really Is the Loneliest Number
- MOGAD has unique immune signature distinct from MS: Study
- FDA approves generic version of Vumerity for relapsing MS
- New Biological Mechanism Boosts Myelin Production in the Brain
- 4 Vitamin B12 Deficiency Symptoms You Need to Know
- Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
- Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- UIC Study: Remote Pilates Program for People Living with MS
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
- Trigeminal neuralgia and MS
- What Is an MS Zinger and How Can You Manage It?
- What to know about itching and MS
- Two compounds with potential for myelin repair in MS identified
- Losing my sense of safety after an MS relapse
